LEADING THE SLAUGHTER-FREE MEAT REVOLUTION FOR A HEALTHIER WORLD

WELCOME TO ALEPH FARMS

We are shaping the future of food by producing cell-grown meat that resembles farmed meat

BOVINE   MEAT

BOVINE MEAT

VARIOUS CELL TYPES COMPOSING FARMED MEAT

VARIOUS CELL TYPES COMPOSING FARMED MEAT

3D  MEAT TEXTURE

3D MEAT TEXTURE

SETTING A NEW BENCHMARK IN CELL-GROWN MEAT

good food for a healthy world

RESEMBLING FARMED MEAT

At Aleph Farms, we believe meat is one of life’s pleasures, to be celebrated and enjoyed without the downsides to health and the environment. Aleph Farms aims to offer superior, healthier, more humane, slaughter-free meat, with the same taste, texture, and structure as farmed meat – providing a new customer experience.

RESEMBLING_FARMED_MEAT

BETTER FOR US AND BETTER FOR THE PLANET

Slaughter-free meat involves taking a sample of animal cells from a real cow and replicating them outside of the animal: without the antibiotics, environmental footprint, contamination and animal slaughter which comes with conventional meat production.

RESEARCH & DEVELOPMENT

NewSIn

OUR TEAM

Prior to Aleph Farms, Didier was co-founder and CEO of IceCure, which went public in 2010, and CEO of NLT Spine, which was acquired by SeaSpine in 2016. Didier was trained as a Food Engineer and Biologist at AgroSup, and was awarded a Specialized Master degree from ESCP, Europe Business School, in France. In addition, he holds a joint Executive MBA degree from the Kellogg and Recanati business schools, USA and Israel.

Didier Toubia
CEO

Prior to Aleph Farms, Didier was co-founder and CEO of IceCure, which went public in 2010, and CEO of NLT Spine, which was acquired by SeaSpine in 2016. Didier was trained as a Food Engineer and Biologist at AgroSup, and was awarded a Specialized Master degree from ESCP, Europe Business School, in France. In addition, he holds a joint Executive MBA degree from the Kellogg and Recanati business schools, USA and Israel.
Dr. Neta Lavon is an expert in stem cell applications in biotechnology. In her previous position as COO of Kadimastem (KDST) she developed cell therapy products from stem cells for ALS and Diabetes. As a researcher in Cedars-Sinai in Los Angeles, USA, she established and banked 25 novel pluripotent stem cell lines. She holds a PhD, an M.Sc. in Biotechnology and B.Sc. in Food Sciences from Hebrew University, Israel.

Neta Lavon
VP R&D

Dr. Neta Lavon is an expert in stem cell applications in biotechnology. In her previous position as COO of Kadimastem (KDST) she developed cell therapy products from stem cells for ALS and Diabetes. As a researcher in Cedars-Sinai in Los Angeles, USA, she established and banked 25 novel pluripotent stem cell lines. She holds a PhD, an M.Sc. in Biotechnology and B.Sc. in Food Sciences from Hebrew University, Israel.
Prof. Shulamit Levenberg is Dean of the Faculty of Biomedical Engineering, Technion Institute of Technology, Israel. Her discoveries pertaining to vascularization of stem cell-derived tissue constructs are discussed in Nature-Biotechnology, PNAS, Tissue Engineering, Circulation Research and other journals, and have left a significant imprint on the scientific community. She holds a PhD from the Weizmann Institute of Science, Israel and a Post-Doctorate from the MIT, USA.

Prof. Shulamit Levenberg
CSO

Prof. Shulamit Levenberg is Dean of the Faculty of Biomedical Engineering, Technion Institute of Technology, Israel. Her discoveries pertaining to vascularization of stem cell-derived tissue constructs are discussed in Nature-Biotechnology, PNAS, Tissue Engineering, Circulation Research and other journals, and have left a significant imprint on the scientific community. She holds a PhD from the Weizmann Institute of Science, Israel and a Post-Doctorate from the MIT, USA.

ALEPH FARM IS GROWING FAST!

If you’d like to be part of a dynamic company that’s creating a new breed of value-added, animal products
we’d love to hear from you!

OUR PARTNERS

lp1
lp2
lp3

NEWS

CONTACT US